Gene · 5890
Papers1,861
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,861
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Modernising autism spectrum disorder model engineering and treatment via CRISPR-Cas9: A gene reprogramming approach. | World J Clin Cases | 2023 | 37274051 | PubTator, text mining | PubMed |
| Expression profiles and potential roles of serum tRNA‑derived fragments in diabetic nephropathy. | Exp Ther Med | 2023 | 37273759 | PubTator, text mining | PubMed |
| PARP Inhibitors in Ovarian Cancer: A Review. | Target Oncol | 2023 | 37268756 | PubTator, text mining | PubMed |
| Genomic and molecular landscape of homologous recombination deficiency across multiple cancer types. | Sci Rep | 2023 | 37264024 | PubTator, text mining | PubMed |
| Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C. | Cancer Res | 2023 | 37253112 | PubTator, text mining | PubMed |
| Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer. | Int J Mol Sci | 2023 | 37240349 | PubTator, text mining | PubMed |
| Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer. | Int J Mol Sci | 2023 | 37240284 | PubTator, text mining | PubMed |
| DNA Repair Pathway in Ovarian Cancer Patients Treated with HIPEC. | Int J Mol Sci | 2023 | 37240218 | PubTator, text mining | PubMed |
| Bre1/RNF20 promotes Rad51-mediated strand exchange and antagonizes the Srs2/FBH1 helicases. | Nat Commun | 2023 | 37230987 | PubTator, text mining | PubMed |
| Improving the efficacy of combined radiotherapy and immunotherapy: focusing on the effects of radiosensitivity. | Radiat Oncol | 2023 | 37226275 | PubTator, text mining | PubMed |
| Spatial and temporal intra-tumoral heterogeneity in advanced HGSOC: Implications for surgical and clinical outcomes. | Cell Rep Med | 2023 | 37220750 | PubTator, text mining | PubMed |
| Pulmonary adenoid cystic carcinoma: molecular characteristics and literature review. | Diagn Pathol | 2023 | 37198615 | PubTator, text mining | PubMed |
| Comparative Genomic Landscape of Urothelial Carcinoma of the Bladder Among Patients of East and South Asian Genomic Ancestry. | Oncologist | 2023 | 37196060 | PubTator, text mining | PubMed |
| PARP Inhibitors in Breast and Ovarian Cancer. | Cancers (Basel) | 2023 | 37190285 | PubTator, text mining | PubMed |
| Noncanonical Roles of RAD51. | Cells | 2023 | 37190078 | PubTator, text mining | PubMed |
| Gene Fusion Detection in NSCLC Routine Clinical Practice: Targeted-NGS or FISH? | Cells | 2023 | 37190044 | PubTator, text mining | PubMed |
| Management of Advanced Prostate Cancer in the Precision Oncology Era. | Cancers (Basel) | 2023 | 37174018 | PubTator, text mining | PubMed |
| Mutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Advanced-Stage Breast Carcinoma. | Cancers (Basel) | 2023 | 37173992 | PubTator, text mining | PubMed |
| Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome. | J Gynecol Oncol | 2023 | 37170728 | PubTator, text mining | PubMed |
| PARP inhibitors in metastatic prostate cancer. | Front Oncol | 2023 | 37168382 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5890/papers?page=12